Top Markets
#1 Orochi Network Orochi Network +75.87%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +26.10%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.22%
#7 DeXe DeXe +14.77%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 Cheems Token Cheems Token +13.12%
Coin of the day
Orochi Network Orochi Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rangering i aksjer #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aksjekurs
$50.93
Markedsverdi
$226.32B
Endring (1 dag)
2.54%
Endring (1 år)
-26.19%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategori

Healthcare
P/S-forhold for Novo Nordisk A/S (NVO)
P/S-forhold per July 2026 TTM: 4.33
Ifølge Novo Nordisk A/S sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 4.33. Ved slutten av 2024 hadde selskapet et P/S-forhold på 9.57.
P/S-historikk for Novo Nordisk A/S fra 2000 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 4.33 -7.42%
2025 4.68 -51.16%
2024 9.57 -28.95%
2023 13.47 12.21%
2022 12.01 0.14%
2021 11.99 52.88%
2020 7.84 4.26%
2019 7.52 14.27%
2018 6.58 -10.96%
2017 7.39 28.28%
2016 5.76 -39.48%
2015 9.53 23.95%
2014 7.69 20.58%
2013 6.37 -2.85%
2012 6.56 16.63%
2011 5.62 -6.38%
2010 6.01 54.26%
2009 3.89 6.22%
2008 3.67 -25.10%
2007 4.90 23.93%
2006 3.95 14.37%
2005 3.45 -0.13%
2004 3.46 11.99%
2003 3.09 9.60%
2002 2.82 -43.18%
2001 4.96 6.86%
2000 4.64 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.86 127.68%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.53 4.57%
US
UCB SA UCB SA
UCB SA
UCB.BR
5.72 31.96%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.03 269.94%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
8.76 102.17%
US